首页> 外文会议>Proceedings of the 18th congress of the International Society for Mushroom Science >Research and Development of a Ganoderma lucidum Polysaccharide Injection Formulation
【24h】

Research and Development of a Ganoderma lucidum Polysaccharide Injection Formulation

机译:灵芝多糖注射剂的研制

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to investigate the effect of injecting polysaccharides from Ganoderma lucidum into hosts for clinical practice. The polysaccharide aqueous extracts of Ganoderma lucidum' s fruit body was purified by Deproteinization of Sevage method, anion-exchange chromatography elution, dialysis, ethanol precipitation, active carbon filter, and millipore membrane filter technique. The injection was prepared from purified Ganoderma lucidum polysaccharide (GLPS). Polysaccharide indexes, protein, tannin, heavy metal, arsenic salt, oxalate, potassium ion, resin, pH, ignition residue, evaluation criterion of allergic reaction, total solids content of the GLPS injection were all tested with the reference method in Chinese Pharmacopoeia (2010ed). The results showed that the key component of injection was polysaccharide, ignition residue and total solids content were 1.4% and 2. 4%, respectively, the other indices were all within expected safety ranges. Notably, the injection improved the antifatigue capacity of mice with no effect in weight.
机译:这项研究的目的是研究将灵芝多糖注射入宿主的临床实践效果。灵芝子实体的多糖水提物采用Sevage脱蛋白法,阴离子交换色谱法洗脱,透析,乙醇沉淀,活性炭过滤和微孔膜过滤技术进行纯化。注射剂由纯化的灵芝多糖(GLPS)制备。 GLPS注射液的多糖指标,蛋白质,单宁,重金属,砷盐,草酸盐,钾离子,树脂,pH,灼烧残渣,过敏反应评估标准,总固体含量均通过《中国药典》(2010年版)。结果表明,注射剂的主要成分为多糖,着火残留物和总固体含量分别为1.4%和2. 4%,其他指标均在预期的安全范围内。值得注意的是,该注射剂改善了小鼠的抗疲劳能力,而对体重没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号